Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse DOI: 10.1038/s41591-019-0593-1
Profiling of circulating free DNA using targeted and genome wide sequencing in patients with Small Cell Lung Cancer DOI: 10.1016/j.jtho.2019.10.007
Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial DOI: 10.1016/j.ygyno.2020.01.005
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity DOI: 10.1038/s43018-020-0046-2
The rare YAP1 subtype of Small Cell Lung Cancer revisited in a biobank of 39 Circulating Tumour Cell Patient Derived eXplant models (CDX): A brief report DOI: 10.1016/j.jtho.2020.07.008
The biomolecule corona of lipid nanoparticles contains circulating cell-free DNA DOI: 10.1039/d0nh00333f
A model of k-mer surprisal to quantify local sequence information content surrounding splice regions DOI: 10.7717/peerj.10063
Brief report on the clinical characteristics of patients whose samples generate small cell lung cancer circulating tumour cell derived explants DOI: 10.1016/j.lungcan.2020.11.002
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome DOI: 10.1016/j.esmoop.2020.100005
